Document Detail


Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome.
MedLine Citation:
PMID:  20029224     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Polycystic ovarian syndrome (PCOS) is the most common cause of anovulatory infertility worldwide. In addition to a poor conception rate, pregnancy loss rates are significantly higher (30-50%) during the first trimester in women with PCOS. Insulin resistance (IR) in this syndrome is not only implicated toward early pregnancy loss (EPL) but also pathognomic for various obstetrical complications during pregnancy. We evaluated the role of Metformin in the reduction of EPL in women with PCOS who conceived spontaneously or after induction ovulation with or without Metformin. OBJECTIVE: The primary objective was to evaluate the effectiveness of Metformin in the reduction of EPL in women with PCOS. Secondary outcomes like gestational diabetes, pregnancy-induced hypertension and intrauterine growth restriction were also analyzed at the end of the study. MATERIAL AND METHODS: This case-control study was conducted from March 2005 to March 2008 in the infertility and antenatal clinics of the Department of Obstetrics and Gynecology of Aga Khan University Hospital, Karachi, Pakistan. A total of 197 infertile women with PCOS were included. 'Cases' were women with PCOS who conceived while taking Metformin and it whom it was continued throughout pregnancy. 'Controls' were women in whom Metformin was either stopped in first trimester after confirmation of pregnancy (by serum betaHCG or by ultrasound) or they conceived spontaneously without the use of Metformin. RESULTS: All 197 women in this study had a confirmed diagnosis of PCOS (Rotterdam criteria). These women were followed till the final outcome of pregnancy was achieved. Both groups were compared for risk of EPL. It was found that continuation of Metformin during pregnancy reduces EPL, i.e. 8.8 vs. 29.4% in cases and controls, respectively (p < 0.001). In the subset of women with a prior history of miscarriage, the pregnancy loss rate was 12.5% in the Metformin versus 49.4% in control group (p = 0.002). CONCLUSION: Metformin continuation during pregnancy significantly reduces EPL in women with PCOS. IR may play a significant role in EPL.
Authors:
Fauzia Haq Nawaz; Javed Rizvi
Related Documents :
7789554 - The effects of immunosuppression on development and progression of endometriosis in bab...
7827444 - Subzonal insemination (suzi) or in vitro fertilization (ivf) in microdroplets for the t...
12398224 - Physiopathological determinants of human infertility.
8099024 - Endometriosis symptoms and the limitations of pathology-based classification of severity.
16726164 - A technique for sexing mouse embryos by a visual colorimetric assay of the x-linked enz...
15451574 - Inhibins and activins in human fetal abnormalities.
Publication Detail:
Type:  Controlled Clinical Trial; Journal Article     Date:  2009-12-21
Journal Detail:
Title:  Gynecologic and obstetric investigation     Volume:  69     ISSN:  1423-002X     ISO Abbreviation:  Gynecol. Obstet. Invest.     Publication Date:  2010  
Date Detail:
Created Date:  2010-04-14     Completed Date:  2010-07-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7900587     Medline TA:  Gynecol Obstet Invest     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  184-9     Citation Subset:  IM    
Copyright Information:
Copyright 2009 S. Karger AG, Basel.
Affiliation:
Department Obstetrics and Gynecology, Aga Khan University Hospital, Karachi, Pakistan. fauzia.nawaz@aku.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortion, Habitual / epidemiology,  prevention & control*
Adult
Body Mass Index
Case-Control Studies
Diabetes, Gestational / drug therapy,  epidemiology
Female
Fetal Growth Retardation / epidemiology
Humans
Hypertension, Pregnancy-Induced / epidemiology
Hypoglycemic Agents / administration & dosage*
Insulin Resistance
Metformin / administration & dosage*
Obesity / drug therapy*,  epidemiology
Pakistan / epidemiology
Polycystic Ovary Syndrome / drug therapy*,  epidemiology
Pregnancy
Pregnancy Trimester, First
Risk Factors
Treatment Outcome
Young Adult
Chemical
Reg. No./Substance:
0/Hypoglycemic Agents; 657-24-9/Metformin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  In-Office Thermachoice III Ablation: A Comparison of Two Anesthetic Techniques.
Next Document:  Severe Transient Leukopenia following Hysterosalpingography.